Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Chemocentryx Inc
(NQ:
CCXI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 19, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Chemocentryx Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Futures Slide As Soaring Oil Nears $85
October 11, 2021
While cash bonds may be closed, one can easily extrapolate where they would be trading based on TSY futures which are currently trading at a 1.65% equivalent.
Via
Talk Markets
Topics
Bonds
Exposures
Debt Markets
10 Biggest Price Target Changes For Monday
October 11, 2021
Keybanc lifted Netflix, Inc. (NASDAQ: NFLX) price target from $645 to $670. Netflix shares rose 0.1% to $633.00 in pre-market trading. JMP Securities raised ServiceNow, Inc. (...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Down; Crude Oil Jumps 2%
October 11, 2021
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Nasdaq dropped around 75 points in the previous session. Futures for the Dow Jones Industrial...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
35 Biggest Movers From Friday
October 11, 2021
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for...
Via
Benzinga
Exposures
Product Safety
5 Stocks To Watch For October 11, 2021
October 11, 2021
Some of the stocks that may grab investor focus today are: Mandiant Inc (NASDAQ: MNDT) reported the completion of divestiture of its FireEye Products unit to McAfee Enterprise...
Via
Benzinga
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive stocks and into risky bets...
Via
Talk Markets
Exposures
Product Safety
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive...
Via
Benzinga
Exposures
Product Safety
Why ChemoCentryx Stock Skyrocketed Today
October 08, 2021
Investors are excited about the biotech's game-changing new drug.
Via
The Motley Fool
Mid-Afternoon Market Update: Dow Surges 80 Points; ChemoCentryx Shares Spike Higher
October 08, 2021
Toward the end of trading Friday, the Dow traded up 0.24% to 34,835.06 while the NASDAQ fell 0.13% to 14,635.04. The S&P also rose, gaining 0.13% to 4,405.69. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ChemoCentryx, Allogene Show the Risks and Rewards of Nasdaq Biotech Stocks
October 08, 2021
The broader market was mixed on Friday.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
October 08, 2021
Gainers ChemoCentryx (NASDAQ:CCXI) stock increased by 70.43% to $33.41 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 74.6...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises 2%; Allogene Therapeutics Shares Plunge
October 08, 2021
Midway through trading Friday, the Dow traded down 0.06% to 34,734.52 while the NASDAQ fell 0.25% to 14,617.60. The S&P also fell, dropping 0.08% to 4,396.09. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
EXCLUSIVE: ChemoCentryx Plans To Start Phase 3 Avacopan Trial In Chronic Skin Disorder In 2022
October 08, 2021
After a tight advisory committee vote back in May tilted just slightly in favor of approving ChemoCentryx Inc's (NASDAQ: CCXI) avacopan, the FDA has cleared the drug...
Via
Benzinga
Exposures
Product Safety
28 Stocks Moving In Friday's Mid-Day Session
October 08, 2021
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil...
Via
Benzinga
Exposures
Product Safety
CCXI Stock: The Big FDA News That Has ChemoCentryx Shares Skyrocketing 60%
October 08, 2021
CCXI stock is making its investors very happy this morning with some huge gains. It's receiving FDA approval for a rare disease treatment.
Via
InvestorPlace
Exposures
Product Safety
Mid-Morning Market Update: Markets Edge Higher; US Economy Adds 194,000 Jobs In September
October 08, 2021
Following the market opening Friday, the Dow traded up 0.12% to 34,796.95 while the NASDAQ rose 0.09% to 14,667.44. The S&P also rose, gaining 0.16% to 4,406.93. The U.S. has...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 08, 2021
Gainers ChemoCentryx (NASDAQ:CCXI) shares rose 77.65% to $34.82 during Friday's pre-market session. The company's market cap stands at $2.4 billion. eFFECTOR...
Via
Benzinga
Why Did ChemoCentryx Shares Soar 70% On Friday Premarket?
October 08, 2021
The FDA has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil cytoplasmic autoantibody-associated...
Via
Benzinga
Exposures
Product Safety
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs, And More
October 03, 2021
Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Here are the key catalysts that could move stocks in the unfolding...
Via
Talk Markets
Exposures
Product Safety
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
October 03, 2021
Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Positive tidings from Merck & Co...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
October 01, 2021
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...
Via
Benzinga
51 Biggest Movers From Yesterday
October 01, 2021
Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported Q2...
Via
Benzinga
ChemoCentryx Stock Needs To Hold At Support Or It May Slide Lower
September 30, 2021
ChemoCentryx Inc (NASDAQ: CCXI) shares are trading lower Thursday, although there looks to be no company-evident news to explain the jump in share price. The stock was...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 30, 2021
Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current volume of 70.4 million shares is 943.37% of Progenity...
Via
Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
September 30, 2021
Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 55% to $13.00. Paltalk engaged ClearThink to lead expanded investor relations program. Farmmi, Inc. (NASDAQ: FAMI) jumped 45.5...
Via
Benzinga
Why Are ChemoCentryx's Shares Trading Higher Today?
September 27, 2021
ChemoCentryx Inc's (NASDAQ: CCXI) partner Kissei Pharmaceutical Co Ltd has received approval from the Japanese Ministry of Health, Labor, and Welfare...
Via
Benzinga
22 Stocks Moving in Friday's Pre-Market Session
September 24, 2021
Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 42% to $15.24 in pre-market trading. The company’s shares jumped around 65% over the previous month. vTv Therapeutics Inc...
Via
Benzinga
2 Growth Stocks That Could Take Off Before the End of the Year
September 16, 2021
They've been struggling thus far in 2021, but things could turn around quickly for these companies.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.